Clinical Trial Update: Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating memory outcomes and MRI changes with hippocampus-avoidance prophylactic cranial irradiation in small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN